Cancer R&D 2024 has wrapped up successfully. We’re grateful for your interest and interaction with Alfa Cytology. We’re eager to continue providing our expertise in cancer drug development. Let’s look back on these memorable moments!
Learn MoreTranscriptomics analysis is a powerful tool for identifying early and high-risk mutations in tumor progression, making it invaluable for discovering new tumor biomarkers and potential therapeutic targets. With our advanced next-generation sequencing technology, Alfa Cytology offers comprehensive transcriptomics analysis services specifically designed for brain tumors.
The transcriptome represents the entire collection of transcripts within a cell, including messenger RNA (mRNA), non-coding RNAs and small RNAs. Through the comprehensive decoding of these transcripts, researchers are able to explore gene expression patterns and cellular variability, which not only elucidates the intricate mechanisms governing cellular functions but also reveals the multifaceted roles played by different RNAs, providing a deeper understanding of the intricate molecular landscape within cells.
Fig.1 Applications of spatial transcriptomics in cancer research. (Park HE., et al., 2023)
Transcriptomics serves as a crucial tool in brain tumor research, especially for the identification of brain tumor subpopulations, heterogeneity and potential biomarkers. By delving into the gene expression profiles of brain tumors, transcriptomics not only assists in understanding the molecular intricacies driving brain tumor advancement but also paves the way for the accelerated discovery and development of innovative therapeutic approaches tailored specifically for combating brain tumors.
Alfa Cytology utilizes advanced transcriptome technology to accurately detect gene expression patterns within brain tumor tissues. Our advanced transcriptomics analysis allows our clients to characterize cellular interactions and organization in situ and obtain valuable information for biomarker discovery and novel therapy approaches.
Service Options | Description |
RNA Sequencing (RNA-Seq) Analysis | Offering a suite of comprehensive RNA sequencing services, encompassing whole transcriptome sequencing, single-cell RNA sequencing and targeted sequencing for brain tumors. |
Microarray Analysis | Offering a complete range of arrays for whole-transcriptome and noncoding RNA analysis tailored to your brain tumor research. |
Noncoding RNA Analysis | Providing professional noncoding RNA Analysis, including long noncoding RNA (lncRNA) sequencing and profiling of microRNAs and other small noncoding RNAs. |
Spatial Transcriptomics Analysis | Providing professional and well-established spatial transcriptomics analysis to map gene expression within the spatial context of brain tumors. |
Quantitative Real-Time PCR (qPCR) | Providing highly sensitive quantification of specific RNA transcripts with specificity. |
Sample Preparation
Transcriptome Sequencing
Library Construction
Data Analysis
Utilizing cutting-edge technologies, specialized expertise and advanced data analysis, we empower researchers to delve into the intricate world of transcriptional dynamics, gene expression control, splicing variations and the intricate web of gene interactions. Alfa Cytology serves as a swift avenue for investigating how transcriptional processes impact cellular functions and identifying promising therapeutic targets tailored to brain tumor research. For further details on our services, please feel free to contact us.
Reference